What is NDC 24979-715?

24979-715 is the product NDC for sorafenib, Sorafenib 200 mg/1 tablet, film coated, listed with the FDA by Upsher-Smith Laboratories, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Upsher-Smith Laboratories, LLC, NDC labeler code 24979. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for sorafenib?

5 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

sorafenib NDC 24979-715 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)24979-715Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24979-0715Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
24979-715-04	2497907150424979071504	60 TABLET, FILM COATED in 1 BOTTLE (24979-715-04)Marketed from Dec 1, 2022
24979-715-44	2497907154424979071544	120 TABLET, FILM COATED in 1 BOTTLE (24979-715-44)Marketed from Dec 1, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): sorafenib
Generic name (nonproprietary): sorafenib
Active ingredients: Sorafenib — 200 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Upsher-Smith Laboratories, LLCNDC labeler code 24979
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209050
Marketing start: Dec 1, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Protein Kinase Inhibitors (Mechanism)
Identifiers: Product ID 24979-715_55afb5e2-d3ae-6c46-e063-6394a90adec2SPL ID 55afb5e2-d3ae-6c46-e063-6394a90adec2SPL set ID 68aa4b7f-3f13-4e73-b572-aa6c11a8429cRxCUI 597747UNII 9ZOQ3TZI87UPC 0324979715445
Pharmacologic class: Kinase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424979071504 followed by a unit qualifier and the quantity

Package 24979-0715-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 3, 2026.

Indications (excerpt from the label)

Sorafenib tablets are a kinase inhibitor indicated for the treatment of Unresectable hepatocellular carcinoma(1.1) Locally recurrent or metastatic, progressive, differentiated thyroid carcinoma (DTC) refractory to radioactive iodine treatment (1.3) 1.1 Hepatocellular Carcinoma Sorafenib tablets are indicated for the treatment of patients with unresectable hepatocellular carcinoma (HCC). 1.3 Differentiated Thyroid Carcinoma Sorafenib tablets are indicated for the treatment of patients with locally recurrent or metastatic, progressive,differentiated thyroid carcinoma (DTC) that is refractory to radioactive iodine treatment.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 24979-715

What is NDC 24979-715?: 24979-715 is the product NDC for sorafenib, Sorafenib 200 mg/1 tablet, film coated, listed with the FDA by Upsher-Smith Laboratories, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: sorafenib.
What is the active ingredient?: Sorafenib.
Who is the labeler?: Upsher-Smith Laboratories, LLC, NDC labeler code 24979. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for sorafenib?: 5 other product NDCs are listed under this name. See all sorafenib NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other sorafenib NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Sorafenib	Sorafenib 200 mg/1	Tablet, Film coatedOral	Torrent Pharmaceuticals Limited	13668-682	13668-0682-1213668-0682-3013668-0682-60+1 more
Sorafenib	Sorafenib tosylate 200 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals, Inc.	0480-5425	00480-5425-89
sorafenib	Sorafenib 200 mg/1	Tablet, Film coatedOral	Yabao Pharmaceutical Co., Ltd. Beijing	51990-201	51990-0201-0651990-0201-12
sorafenib	Sorafenib 200 mg/1	Tablet, Film coatedOral	Golden State Medical Supply, Inc.	51407-760	51407-0760-12
sorafenib	Sorafenib tosylate 200 mg/1	Tablet, Film coatedOral	Dr.Reddys Laboratories Inc	43598-458	43598-0458-0443598-0458-36

Other NDCs under ANDA 209050

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209050
Product	Strength	Form · route	Labeler	Product NDC
sorafenib	Sorafenib 200 mg/1	Tablet, Film coatedOral	Golden State Medical Supply, Inc.	51407-760
sorafenib	Sorafenib 200 mg/1	Tablet, Film coatedOral	Yabao Pharmaceutical Co., Ltd. Beijing	51990-201